Thursday, February 25, 2010

Glaxo denies concealing Avandia caused heart risks

GlaxoSmithKline has released a 30-page rebuttal to the U.S. Senate report that accused the company of intentionally trying to conceal potential heart problems with Avandia. Go here for the full story and helpful links. Check this post later for updates. I will continue to link to new stories throughout the day if I find any new ones. UPDATES: Story about Glaxo's rebuttal document in Pharmalot

No comments: